Marcum’s NorCal Assurance Team Stuns Client with In-Depth Industry Expertise and Quick Turnaround Time
Understanding the importance of maintaining compliance with grant regulations, the Company’s founder and CEO stated, “I cannot speak highly enough of Marcum. Greg [Zoll] and his team completed a detailed audit in less than 30 days, ensuring compliance with NIH grant funding requirements. Marcum’s excellent work ensures that we will have the opportunity to continue to secure substantial NIH funding for biotechnology R&D work in the years ahead. I look forward to continue working with Greg and his team in the future.
ABOUT THE CLIENT
An early stage biotechnology company currently developing a novel device for ocular anesthesia based on thermo-electric cooling. This device will speed up the anesthesia process for intravitreal injection therapy, one of the most commonly performed procedures in all of medicine with over 7 million injections in the United States per year, in addition to eliminating negative side effects of short term post-injection pain and blurred vision current anesthetics often cause.
THE CHALLENGEMarcum was engaged to perform a program-specific audit of the company’s NIH grant expenditures a month before the regulatory deadline for completion. For a company that has never experienced an audit, the process of gathering and preparing all of the information required can be intimidating and time–consuming.
Ensure the audit was completed and submitted to the NIH by the regulatory deadline.